Sign up for our Newsletter
Subscribe to get the latest insights on Curative’s newest, innovative health services.
Leadership Team
Fred
Turner
CEO, Co-Founder
Fred Turner is the Chief Executive Officer and co-founder of Curative. A British scientist from West Yorkshire, Turner attended the University of Oxford. Mr. Turner was named one of the top 100 practicing scientists in the UK by the Science Council 2013. Turner was included in Forbes “30 Under 30” list and ranked first in the European Union Contest for Young Scientists. Curative has been critical and a national leader in bringing COVID-19 testing and vaccine-administration resources in response to the pandemic, having provided more than 32 million tests and two million vaccines across thousands of locations in 40+ states.
Concurrently, Curative has created and launched a first-of-its-kind health insurance plan offering that offers unmatched transparency into health care costs. Curative is working to remake our health care system into one that works for and supports patients’ whole health and well-being through every step of their personal health journey. The Curative health plan has no copays, no deductibles, no cost-sharing for its members.
Turner previously founded and led a 16z and YC-backed diagnostics (Dx) startup that built a CLIA lab for validating and launching an STD testing product in Menlo Park, California.
Isaac
Turner
CTO, Co-Founder
Dr. Isaac Turner is Chief Technology Officer and a co-founder of Curative. During his career, he has developed algorithms for interpreting Illumina and Oxford Nanopore sequencing data and is passionate about taking technical innovation into the clinic and scaling these processes - making better diagnostics available to millions of patients. Previously at an a16z-backed biotech startup, Dr. Turner helped establish a clinical lab offering novel antibiotic susceptibility tests. He holds a PhD in Bioinformatics from Oxford in DNA sequence analysis.
Tami
Wilson-Ciranna
CFO
Tami Wilson-Ciranna is CFO and has an extensive financial and leadership background in a variety of industries specializing in high growth companies. She uses her leadership experience to structure organizations to allow accelerated growth. Previously, she was CFO of Prolacta Bioscience, Inc. a high growth biotech company, and prior to that CFO of CommonWealth Partners an investment management company. She is a CPA and has her MBA from UCLA.
Beth
Henry
CMO
Beth Henry is CMO and a proven senior executive with 20+ years of experience in health care. Prior to joining Curative, she most recently served as Vice President and CMO of the U.S. Medical Business for Cigna Health Care. In this role, Beth led the team that developed and executed marketing strategies to drive growth for both the Commercial and Government segments and was accountable for bringing the business value proposition to life. Beth has a bachelor’s degree in Economics from Bryn Mawr College and an MBA in Finance from New York University’s Stern School of Business.
Katherine
Frierdich
General Counsel
Katherine Frierdich, JD, MBA, is General Counsel of Curative. Prior to joining, Katherine spent 15 years as a litigator with Bryan Cave LLP. She also worked as Regional General Counsel to numerous Centene-owned health plans offering managed care and commercial plans, and as General Counsel on the provider side.
Sharon
J. Alvis
Market President
Sharon Alvis has over 35 years executive health care experience having served in senior
management positions for multiple start-ups. She now serves as President of Curative health insurance plan and administration. Prior, whe served as President of Vista360health, an HMO, and was responsible for overall plan creation and management. She was Regional VP,
Texas & Louisiana for a Medicare Advantage Plan. Additionally, Sharon was CEO for a Physician Hospital Organization (PHO) representing 450 physicians and 3 hospitals and she developed and served as Executive Director for a hospital-based PPO. Her diversity of experience serving both providers and payors offers insight into the distinct viewpoints of the varied industry stakeholders that Curative seeks to serve.
David “Deke”
Ellwanger
SVP of Development
David “Deke” Ellwanger has spent the last 37 years in the health care industry. He is currently the SVP of Development at Curative and oversees expanding the Curative product across Texas and other markets. He was a President for a division of Healthways, the country’s largest population health management company, President of HealthSpring, COO for Windsor Health Plans, and a Regional Vice President for Aetna’s second largest market. He built or acquired over 15 HMOs. In addition, he has operated physician practices as well as working in the hospital setting. Deke was part of three separate executive teams successfully taking three companies public.
Crystal
Riggs
VP of Pharmacy Services
Crystal Riggs, PharmD, FASCP, is the Vice President, Pharmacy Services. She leads the organization’s pharmacy strategy. Dr. Riggs is an experienced clinical leader and pharmacist with over 25 years of health care experience including over 13 years in managed care. Prior to joining Curative, Dr. Riggs led the Managed Markets team at Smith and Nephew. Previously, Dr.
Riggs led the Pharmacy Clinical Affairs team at Aetna and has held other leadership roles at Express Scripts, CVS Health, Navitus Health Solutions, Cardinal Health, Walgreens, PharMerica and Kindred Healthcare. Dr. Riggs received her Doctor of Pharmacy (PharmD) degree from the University of Missouri, Kansas City.
Jeannie
Smith
SVP of Customer Success
Jeannie Smith is the Sr Vice President of Customer Success at Curative. She brings over 25 years of experience in Customer Success to her role and has been with Curative since its inception building a Customer Care (emphasis on Care) experience that is second to none. Jeannie has held Customer Care and Success leadership roles in multiple business disciplines and brings a unique and creative perspective on how to care for you and your family as if they were our own.
